HCW Biologics Inc. (HCWB)
2.48
-0.03
(-1.20%)
USD |
NASDAQ |
Sep 09, 11:20
HCW Biologics Total Assets (Quarterly) : 26.77M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.77M |
| March 31, 2026 | 27.34M |
| December 31, 2025 | 24.52M |
| September 30, 2025 | 25.45M |
| June 30, 2025 | 28.91M |
| March 31, 2025 | 26.29M |
| December 31, 2024 | 30.24M |
| September 30, 2024 | 26.56M |
| June 30, 2024 | 26.82M |
| March 31, 2024 | 30.43M |
| December 31, 2023 | 28.51M |
| Date | Value |
|---|---|
| September 30, 2023 | 35.62M |
| June 30, 2023 | 39.48M |
| March 31, 2023 | 43.53M |
| December 31, 2022 | 46.81M |
| September 30, 2022 | 51.35M |
| June 30, 2022 | 47.41M |
| March 31, 2022 | 50.96M |
| December 31, 2021 | 53.51M |
| September 30, 2021 | 56.41M |
| June 30, 2021 | 13.03M |
| March 31, 2021 | 12.93M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.34M |
| Shareholders Equity (Quarterly) | 7.428M |
| Debt to Equity Ratio | 0.8834 |
| Current Ratio | 0.0611 |
| Net Debt Paydown Yield | 18.28% |